Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Diehm

Showing results (91-100 of 165) with videos related to

Pageof 17
Sort By:
MMW Fortschritte Der Medizin|October 31, 2003
[Risk of vascular occlusion in your patient? With the ankle-arm index general practitioners discover the risk much earlier]C Diehm, H J Trampisch, B von Stritzky, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 14, 2002
Transdermal application of prostaglandin E1 ethyl ester for the treatment of trophic acral skin lesions in a patient with systemic sclerodermaA Schlez, M Kittel, B Scheurle, et al.
Deutsche Medizinische Wochenschrift (1946)|November 15, 1996
[The prevalence of hyperhomocysteinemia in thromboangiitis obliterans. Does homocysteine play a role pathogenetically?]F Stammler, C Diehm, E Hsu, et al.
VASA. Supplementum|January 1, 1991
[Acute effects of special water gymnastics on the venous system of patients with chronic venous insufficiency]T Weiss, H Elsässer, C Victor, et al.
Deutsche Medizinische Wochenschrift (1946)|May 20, 1988
[Significance of acetylsalicylic acid in the secondary prevention of peripheral arterial occlusive diseases]H H Eckstein, U Müller-Bühl, R Zimmermann, et al.
Deutsche Medizinische Wochenschrift (1946)|June 12, 1987
[Prostaglandin E1 in stage III and IV arterial occlusive diseases. results of a multicenter study]G Trübestein, M Ludwig, C Diehm, et al.
VASA. Supplementum|January 1, 1989
Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled studyC Diehm, A Kühn, R Strauss, et al.
VASA. Supplementum|January 1, 1990
[Does infusion therapy in trained patients with intermittent claudication have advantages?]T Weiss, C Wilhelm, C Hübsch-Müller, et al.
Der Internist|November 25, 1998
[Secondary prevention of atherosclerosis in routine practice]M Christ, H C Diener, T Kurth, et al.
MMW, Munchener Medizinische Wochenschrift|September 25, 1981
[Ambulant treatment of hypertension with cardiotensin (author's transl)]C Diehm, H Mörl, U Müller-Bühl, et al.
Pageof 17

Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
MMW Fortschritte Der Medizin|October 31, 2003
[Risk of vascular occlusion in your patient? With the ankle-arm index general practitioners discover the risk much earlier]C Diehm, H J Trampisch, B von Stritzky, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 14, 2002
Transdermal application of prostaglandin E1 ethyl ester for the treatment of trophic acral skin lesions in a patient with systemic sclerodermaA Schlez, M Kittel, B Scheurle, et al.
Deutsche Medizinische Wochenschrift (1946)|November 15, 1996
[The prevalence of hyperhomocysteinemia in thromboangiitis obliterans. Does homocysteine play a role pathogenetically?]F Stammler, C Diehm, E Hsu, et al.
VASA. Supplementum|January 1, 1991
[Acute effects of special water gymnastics on the venous system of patients with chronic venous insufficiency]T Weiss, H Elsässer, C Victor, et al.
Deutsche Medizinische Wochenschrift (1946)|May 20, 1988
[Significance of acetylsalicylic acid in the secondary prevention of peripheral arterial occlusive diseases]H H Eckstein, U Müller-Bühl, R Zimmermann, et al.
Deutsche Medizinische Wochenschrift (1946)|June 12, 1987
[Prostaglandin E1 in stage III and IV arterial occlusive diseases. results of a multicenter study]G Trübestein, M Ludwig, C Diehm, et al.
VASA. Supplementum|January 1, 1989
Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled studyC Diehm, A Kühn, R Strauss, et al.
VASA. Supplementum|January 1, 1990
[Does infusion therapy in trained patients with intermittent claudication have advantages?]T Weiss, C Wilhelm, C Hübsch-Müller, et al.
Der Internist|November 25, 1998
[Secondary prevention of atherosclerosis in routine practice]M Christ, H C Diener, T Kurth, et al.
MMW, Munchener Medizinische Wochenschrift|September 25, 1981
[Ambulant treatment of hypertension with cardiotensin (author's transl)]C Diehm, H Mörl, U Müller-Bühl, et al.
Pageof 17